{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-342371","form_type":"8-K","ticker":"SANA","cik":"0001770121","company_name":"Sana Biotechnology, Inc.","filed_at":"2026-08-10T20:09:40+00:00","discovered_at":"2026-08-10T20:11:00.355851+00:00","generated_at":"2026-08-10T20:11:40.730515+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sana Biotech Q2 2026: Net loss narrows to $63.6M; cash $160.5M, runway into mid-2027","bullets":["Q2 net loss $63.6M ($0.22/sh) vs $93.8M ($0.39) year ago; non-GAAP loss $39.7M ($0.13).","Cash, equivalents, marketable securities $160.5M at 6/30/26; raised $93.3M from ATM and Mayo Clinic's $25M equity investment.","SC451 IND and Phase 1/2 start expected as early as this year; SG293 first-in-human data expected as early as this year.","UP421 14-month data published in NEJM: C-peptide present, no immunosuppression, no safety issues.","Mayo Clinic collaboration to accelerate SC451 development; $25M equity investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-342371","json":"https://secwatch.observer/filing/0001193125-26-342371.json","markdown":"https://secwatch.observer/filing/0001193125-26-342371.md","text":"https://secwatch.observer/filing/0001193125-26-342371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770121/000119312526342371/0001193125-26-342371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770121/000119312526342371/sana-20260810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T20:11:40.730515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}